Buy Samsca
Samsca

$5.02
Delivery
Airmail (14-21 days) | EMS trackable (5-9 days)
Prescription
Issued on site / Included
Availability
In Stock
Product is shipped in a fully discreet envelope with no content disclosure, including all required documentation inside

Samsca Properties

Active Ingredients
Primary Category
Therapeutic Class
Pharmacological Class
Vasopressin Receptor Antagonist
Indications
Minor Side Effects
Moderate Side Effects
Serious Side Effects
Dosage Forms
Tablets
Administration Route
Oral
Mechanism of Action
Helps increase sodium levels in the body by promoting water excretion.
Prescription Status
Rx
Patient Summary
Used to treat low sodium levels in the blood due to certain medical conditions.
Onset Time
Within 2 hours
Duration
24 hours
Storage Instructions
Store at room temperature, away from moisture
Drug Interactions
Age Restrictions
Not for use in children
Pregnancy Use
Consult doctor before use during pregnancy
Alternative Drugs

About Samsca

Samsca is a prescription-only pill that contains the active ingredient tolvaptan, a selective vasopressin V₂-receptor antagonist. In Singapore it is approved for the treatment of euvolemic hyponatraemia, most commonly caused by the syndrome of inappropriate antidiuretic hormone secretion (SIADH), and for slowing the progression of autosomal dominant polycystic kidney disease (ADPKD). By blocking the action of antidiuretic hormone, Samsca promotes the excretion of free water without significant loss of electrolytes, helping to restore normal blood-sodium levels and reduce cyst growth in the kidneys. The medication is available in 15 mg and 30 mg tablets, and its use is guided by careful laboratory monitoring and specialist supervision.

What is Samsca?

Samsca is marketed as a branded formulation of tolvaptan and is classified pharmacologically as a vasopressin V₂-receptor antagonist. The Singapore Health Sciences Authority (HSA) granted approval in 2015 for the management of euvolemic hyponatraemia and, later, for ADPKD in patients at risk of rapid kidney-function decline. Internationally, both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have issued similar approvals, emphasizing its role in conditions where excess antidiuretic hormone leads to water retention. Samsca is supplied as oral tablets of 15 mg and 30 mg strength, with dosing individualized according to serum sodium levels and renal-function parameters.

How Samsca Works

Samsca works by competitively binding to the vasopressin V₂ receptors located on the basolateral membrane of renal collecting-duct cells. Under normal circumstances, vasopressin (antidiuretic hormone) binds these receptors, activating a cascade that inserts aquaporin-2 water channels into the apical membrane, allowing water reabsorption. Tolvaptan blocks this binding, preventing aquaporin-2 insertion and thereby reducing water reabsorption-a process called aquaresis. The net effect is an increase in free-water excretion, which raises serum sodium concentration in hyponatraemic patients. In ADPKD, the same V₂-receptor blockade reduces cyclic AMP (cAMP) production in kidney tubular cells, slowing cyst proliferation and fluid secretion, which translates into a slower decline in glomerular filtration rate (GFR).

Why Samsca is Used for Hormonal Therapies Conditions

  • Euvolemic Hyponatraemia (SIADH) - By promoting water loss without sodium loss, Samsca directly counteracts the water-retention effect of inappropriate vasopressin release, rapidly correcting low serum sodium.
  • Autosomal Dominant Polycystic Kidney Disease - The drug’s inhibition of cAMP-driven cyst growth makes it a disease-modifying therapy, positioning it as a first-line option for patients with rapidly declining kidney function.
  • Heart-Failure-Related Hyponatraemia (off-label) - Limited trials suggest that V₂ antagonism can improve serum sodium and reduce congestion, though it remains outside official labeling in Singapore.
  • Liver-Disease-Associated Hyponatraemia (investigational) - Small-scale studies indicate potential benefit, but hepatic safety concerns require specialist oversight.

Off-Label and Investigational Uses of Samsca

Evidence from randomized controlled trials and observational cohorts indicates that tolvaptan may improve serum sodium in heart-failure patients with refractory hyponatraemia and may attenuate ascites formation in cirrhotic patients. However, the Singapore HSA has not approved these indications, and hepatic toxicity remains a concern. Off-label use should only be considered under the supervision of a qualified healthcare provider, with regular liver-function monitoring.

Is Samsca Right for You?

Samsca is most appropriate for adults who have documented euvolemic hyponatraemia or early-stage ADPKD with evidence of rapid cyst growth. Ideal candidates have stable liver function, no severe hypersensitivity to tolvaptan, and are able to comply with frequent laboratory checks. The medication is contraindicated in patients with anuria, uncontrolled thirst disorders, or those taking strong CYP3A4 inhibitors without dose adjustment. Pregnant or breastfeeding individuals should avoid Samsca unless the benefits clearly outweigh the risks. Elderly patients may require lower starting doses due to altered pharmacokinetics.

Taking Samsca Effectively

  • Initiation: Start with a 15 mg tablet once daily; increase to 30 mg if sodium does not improve after 24 hours and the patient tolerates the drug.
  • Timing: Take the tablet in the morning with a glass of water; avoid taking it after 6 PM to reduce nocturnal polyuria.
  • Food Interactions: Samsca can be taken with or without food, but substantial caffeine or alcohol intake may exacerbate thirst.
  • Missed Dose: If a dose is missed for more than 12 hours, skip it and resume the regular schedule; do not double-dose.
  • Travel: Carry a copy of the prescription and keep the medication in its original container; stay hydrated but monitor urine output closely in hot climates.

Understanding Side Effects and How to Manage Them

  • Increased Thirst & Polyuria: These are direct consequences of aquaresis. Encourage moderate fluid intake (≈2 L/day) and schedule bathroom breaks, especially after the first few doses.
  • Elevated Liver Enzymes: Monitor ALT, AST, and bilirubin at baseline, then monthly for the first three months, and quarterly thereafter. Discontinue if transaminases rise >3 × ULN with symptoms.
  • Hyperuricemia: Periodic uric-acid testing is advisable; lifestyle modifications and, if needed, allopurinol under supervision can mitigate gout risk.
  • Serious Reactions: Rare cases of severe hepatic injury, pancreatitis, or allergic rash require immediate medical attention. Advise patients to seek care if they experience jaundice, persistent abdominal pain, or swelling.

Buying Samsca from Our Online Pharmacy

Why Choose Our Service?

Our online pharmacy bridges the gap for Singapore residents who face limited stock or high out-of-pocket costs at brick-and-mortar dispensaries. By leveraging regulated supply chains, we provide a discreet, reliable route to obtain Samsca when conventional pharmacies fall short.

Quality & Safety

We partner exclusively with licensed international pharmacies that operate under stringent regulatory frameworks such as the WHO Good Distribution Practices. Every batch of Samsca is verified for authenticity, potency, and packaging integrity before shipment.

Pricing & Access

Through bulk procurement and streamlined logistics, we can offer Samsca at a competitive price point-often 20 % lower than local retail rates. For patients who require long-term therapy, we provide a Lifetime 10 % discount on all reorders, making chronic treatment more affordable.

Discreet Delivery

Orders are packed in neutral, tamper-evident boxes and dispatched via express or standard courier. Express shipping typically arrives within 7 days, while standard delivery reaches most Singapore addresses within 3 weeks, all with privacy-first packaging.

Frequently Asked Questions

  • How quickly can I expect my sodium level to rise after starting Samsca? Most patients see a measurable increase in serum sodium within 24 hours, though the full correction may take 48-72 hours depending on baseline severity.

  • Can I use Samsca if I have mild liver dysfunction? Mild, stable liver enzyme elevations may be permissible, but regular monitoring is essential; any significant rise mandates dose reduction or discontinuation.

  • Is there a risk of dehydration while taking Samsca? Because the drug promotes free-water loss, adequate fluid intake is crucial. Dehydration is uncommon if patients follow the recommended hydration guidelines.

  • How does Samsca differ from other vasopressin antagonists like conivaptan? Samsca (tolvaptan) is an oral, selective V₂ antagonist, whereas conivaptan is an intravenous, mixed V₁/V₂ blocker used primarily in acute hospital settings.

  • What should I do if I miss a dose for more than 12 hours? Skip the missed dose and resume the regular schedule; do not double-dose, as this may increase the risk of excessive aquaresis.

  • Can Samsca be taken with other medications for heart failure? Yes, but concurrent use of strong CYP3A4 inhibitors (e.g., ketoconazole) can raise tolvaptan levels; dose adjustment and close monitoring are recommended.

  • Is Samsca covered by Singapore’s Medisave or private insurance? Coverage varies; some private insurers list it under “specialist-prescribed medicines.” Patients should verify benefits with their provider.

  • Does Samsca improve kidney function in ADPKD, or only slow decline? Clinical trials demonstrate a statistically significant slowdown in GFR decline, but the drug does not restore lost kidney function.

  • Are there dietary restrictions while on Samsca? No specific restrictions, but limiting high-salt foods can help stabilize sodium levels and reduce the need for dose escalation.

  • What is the longest duration patients have safely used Samsca? Long-term data from ADPKD trials show safety over a median of 3 years, provided liver-function monitoring is adhered to.

Glossary

Vasopressin V₂-receptor
A protein on kidney-collecting-duct cells that mediates water reabsorption when activated by antidiuretic hormone.
Aquaresis
The excretion of water without accompanying electrolytes, resulting in a net loss of free water.
cAMP (cyclic AMP)
A second messenger that promotes cellular processes such as cyst growth in ADPKD; inhibition reduces disease progression.
Hyponatraemia
A condition characterized by serum sodium concentration below 135 mmol/L, often causing neurological symptoms.
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
A hereditary disorder marked by the development of numerous fluid-filled cysts in the kidneys, leading to progressive renal failure.

Disclaimer

The information provided about Samsca is for general knowledge only and does not replace professional medical consultation. All treatment decisions, including those regarding off-label use, should be made under the supervision of a qualified healthcare provider. We assume all readers are responsible adults capable of making informed decisions about their health. Our online pharmacy offers access to Samsca for individuals who may have limited availability through traditional pharmacies, prescription-based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication.

External Resources about Samsca


Information Prepared By

Nawin Kittisak
Vikneswaran V Paranjothy